|
Cohort II pLGG patients
|
|---|
|
Sample code
|
Age (years)
|
Gender
|
Site of onset
|
Histology
|
Type of resection
|
Progression
|
Progression Free Survival (months)
|
Overall Survival (months)
|
Mutational status
|
|---|
|
ICGC_PA104
|
3
|
F
|
Md Supra
|
PA
|
NTR
|
W/O
|
6
|
6
|
WT
|
|
ICGC_PA144
|
2
|
F
|
Md Supra
|
PA
|
NTR
|
W/O
|
4
|
4
|
CLCN6:BRAF Ex2:Ex11); BRAF p.E451D
|
|
ICGC_PA14
|
5
|
F
|
Md Supra
|
PA
|
NTR
|
W/O
|
23
|
23
|
K15B9
|
|
ICGC_PA159
|
5
|
M
|
Md Supra
|
PA
|
NTR
|
W/O
|
3
|
3
|
QKI:NTRK2 (Ex6:Ex16)
|
|
ICGC_PA4
|
1
|
M
|
Md Supra
|
PA
|
NTR
|
W/O
|
22
|
22
|
K16B9
|
|
ICGC_PA54
|
4
|
F
|
Md Supra
|
PA
|
NTR
|
WITH
|
4
|
12
|
WT
|
|
ICGC_PA69
|
6
|
F
|
Md Supra
|
PA
|
NTR
|
WITH
|
17
|
17
|
NF1 Large deletion (somatic); p.Q1174fs (somatic); FGFR1 p.N546K
|
|
ICGC_PA71
|
2
|
F
|
Md Supra
|
PA
|
NTR
|
WITH
|
5
|
16
|
NF1 p.Q959X (germline); large deletion (somatic)
|
|
ICGC_PA84
|
9
|
M
|
Md Supra
|
PA
|
NTR
|
W/O
|
10
|
10
|
FGFR1 p.K656E; PTPN11 p.E76A
|
- Md Midline, PA Pilocytic Astrocytoma, NTR Near Total Resection, WITH With progression, W/O Without progression
